Self-reported dermatological problems and use of prescribed topical drugs correlate with decreased quality of life: An epidemiological survey

British Journal of Dermatology

Volumn 147, Issue 2, 2002, Pages 285-290

  Bingefors, K ^a   Lindberg, M ^b   Isacson, D ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Epidemiology; Health related quality of life; Short Form 36; Skin disease; Skin problems; Topical dermatological drugs

Indexed keywords

DERMATOLOGICAL AGENT;

ADULT; AGED; ARTICLE; COMORBIDITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG UTILIZATION; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRESCRIPTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SELF REPORT; SEX DIFFERENCE; SKIN DISEASE; SWEDEN;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; DERMATOLOGIC AGENTS; FEMALE; HEALTH SURVEYS; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; PREVALENCE; QUALITY OF LIFE; QUESTIONNAIRES; SKIN DISEASES; SWEDEN;

EID: 0036378096     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2002.04824.x     Document Type: Article

References (40)

1. Williams H. Epidemiology of skin disease. In: Textbook of Dermatology (Champion RH, Burton JL, Burns DA, Breathnach SM, eds). Oxford: Blackwell Science, 1998; 144-8.
2. Hellgren L. An Epidemiological Survey of Skin Diseases Stockholm: Almquist & Wiksell, 1967.
3. Williams H, Naldi L, Diepgen T et al. Epidemiology of skin disease in Europe. In: White Book, Dermatology in Europe (Fritsch P, ed). Bern: European Dermatology Forum, 2001; 5-15.
4. Finlay AY. Dowling Oration 2000. Dermatology patients: what do they really need? Clin Exp Dermatol 2000; 25: 444-50.
5. Apoteksbolaget AB [The National Corporation of Swedish pharmacies]. Svensk Läkemedelsstatistik 1999 [Swedish Drug Statistics 1999]. Stockholm: Apoteksbolaget AB, 1999.
6. Isacson D, Smedby B. Defining heavy use of prescription drugs. A methodological study. Med Care 1988; 26: 1103-10.
7. Finlay AY. Quality of life measurement in dermatology: a practical guide. Br J Dermatol 1997; 136: 305-14.
8. Halioua B, Beumont M, Lunel F. Quality of life in dermatology. Int J Dermatol 2000; 39: 801-6.
9. Ware J, Sherbourne C. The MOS 36 item short form health survey (SF-36). Med Care 1992; 30: 473-83.
10. Zachariae R, Zachariae C, Ibsen H et al. Dermatology Life Quality Index: data from Danish inpatients and outpatients. Acta Derm Venereol (Stockh) 2000; 80: 272-6.
11. Nichol M, Margolies J, Lippa E et al. The application of multiple quality of life instruments in individuals with mild to moderate psoriasis. Pharmacoeconomics 1996; 6: 644-53.
12. Iliev D, Furrer L, Elsner P. Zur Einschätzung der Lebensqualität von Patienten in der Dermatologie. Hautarzt 1998; 49: 453-6.
13. Lundberg L, Johannesson M, Silverdahl M et al. Health related quality of life in patients with psoriasis and atopic dermatitis measured with SF-36, DLQI and a subjective measure of disease activity. Acta Derm Venereol (Stockh) 2000; 80: 430-4.
14. Statistics Sweden. Living Conditions. Appendix 13. In: Technical Report for 1984-85, 1986-87 and 1988-89 Surveys of Living Conditions. Örebro: SCB-Tryck, 1991.
15. Statistics Sweden. Living Conditions. Report no. 76. Health and Medical Care, 1980-89 Örebro: SCB-Tryck, 1992.
16. Thorslund M, Wärneryd B. Methodological research in the Swedish Surveys of Living Conditions. Problems of measurements and data collection. Soc Ind Res 1985; 16: 77-95.
17. Ware J, Snow K, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: New England. Medical Center, 1993.
18. Ware J, Kosinski M, Keller S. SF-36 Physical and Mental Health Summary Scales: a User's Manual. Boston, MA: New England. Medical Center, 1994.
19. SAS Institute Inc. The SAS System for Windows Release 6.12. Cary, NC: SAS, 1996.
20. Antonov K. Pharmacoepidemiological Studies on the Use of Analgesics in Sweden. PhD Thesis. Comprehensive Summaries of Uppsala Dissertations from the Faculty of Pharmacy, Uppsala. Uppsala: Acta Universitatis Upsaliensis, 1997.
21. Rea J, Newhouse M, Halil T. Skin disease in Lambeth: a community study of prevalence and use of medical care. Br J Prev Soc Med 1976; 30: 107-14.
22. Meding B. Normal standards for dermatological health screening at places of work. Contact Dermatitis 1992; 27: 269-70.
23. Meding B, Lidén C, Berglind N. Self-diagnosed dermatitis in adults. Contact Dermatitis 2001; 45: 341-5.
24. Hedberg A. An Inquiry into Relationship between Body Mass Index and Asthma - an Analysis of Data from two Swedish National Registers. MSc Thesis. Stockholm: Karolinska Institute, 1999.
25. Inerot A. Population Genetic Studies of Psoriasis. Thesis. Göteborg: Göteborg University 2000.
26. Wallberg P. A clinical, experimental study of basal cell carcinoma. Aspects on Epidemiology, Genetics and Microphysiology Stockholm: Karolinska Institute, 2000.
27. Lindholm C, Bjellerup M, Christensen O, Zedrefeldt B. A demographic survey of leg and foot ulcer patients in a defined population. Acta Derm Venereol (Stockh) 1992; 72: 227-30.
28. Cleary P. The need and demand for mental health services. In: The Future of Mental Health Services Research (Taube C, Mechanic D, Hohman A. eds). Washington DC: US Department of Health and Human Services, 1989; 161-84.
29. Meininger J. Sex differences in factors associated with use of medical care and alternative illness behaviors. Soc Sci Med 1986; 22: 285-92.
30. Verbrugge LM. Gender and health. an update on hypotheses and evidence. J Health Soc Behav 1985; 26: 156-82.
31. Isacson D. Pharmacological patterns among heavy users of prescription drugs. J Soc Adm Pharm 1987; 5: 12-20.
32. Svarstad BL. Stress and the use of nonprescription drugs: an epidemiological study. Res Commun Ment Health 1983; 3: 233-54.
33. Hibbard JH, Pope CR. Another look at sex differences in the use of medical care: Illness orientation and the types of morbidities for which services are used. Women Health 1986; 11: 21-36.
34. MacIntyre S, Ford G, Hunt K. Do women 'over-report' morbidity? Men's and women's responses to structured prompting on a standard question on long-standing illness. Soc Sci Med 1999; 48: 89-98.
35. Harlow D, Poyner T, Finlay AY, Dykes PJ. Impaired quality of life of adults with skin disease in primary care. Br J Dermatol 2000; 143: 979-82.
36. Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-16.
37. Mallon E, Newton JN, Klassen A et al. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 1999; 140: 672-6.
38. Picardi A, Abeni D, Melchi CF et al. Psychiatric morbidity in dermatological outpatients: an issue to be recognized. Br J Dermatol 2000; 143: 983-91.
39. Hughes JE, Barraclough BM, Hamblin LG, White JE. Psychiatric symptoms in dermatology patients. Br J Psychiatry 1983; 143: 51-4.
40. Aktan S, Ozmen E, Sanli B. Psychiatric disorders in patients attending a dermatology outpatient clinic. Dermatology 1998; 197: 230-4.